# Nope Nope Nurses

> ResidualPlay case file: an overlooked Steam game still earning residual revenue. Estimates carry a ±30-50% error range per title.

- Steam appid: 1846330
- Developer: Dark One!
- Publisher: Shiravune
- Released: 2022 · Genre: Adventure · List price: $19.99
- Deal grade: B (A = dormant with >=$5k/mo opportunity, D = low signal)
- Est. net residual revenue: $897 to $1.3k per month (mid $1.1k)
- Opportunity score: $2.1k/month at x1.85 dormancy multiplier
- Est. lifetime owners: 19.9k · Est. lifetime net revenue: $99.0k
- Review sentiment: 77% positive across 662 reviews (621 from Steam purchases)
- Review velocity: 9.0 reviews/month (6-month average)

## Why it's flagged

- Developer silent for 18 months
- Studio quiet across its whole catalog
- Last build shipped 4.6 years ago
- Store page localized in only 3 language(s)
- Last discounted 0 months ago, 10 sales in the last 12 months
- Proven demand elasticity: x1.5 review velocity during past deep sales

## Where a gross dollar goes (monthly, at current velocity)

| Stage | USD/month |
|---|---|
| Gross storefront sales | $2.0k |
| After VAT / sales tax (-13% blended) | $1.8k |
| After refunds (-9.5% median) | $1.6k |
| Net to developer (after Steam 30%) | $1.1k |

## Monthly review counts, oldest to newest (24 months)

12, 8, 5, 12, 8, 17, 7, 6, 6, 4, 7, 8, 4, 8, 11, 11, 5, 6, 11, 5, 9, 8, 7, 14

## Estimated acquisition range

$26.9k to $53.8k (2-4x the trailing net annuity of $13.5k/year). Same error range applies.

## Markets by review language

- english: 13%
- koreana: 2% (game NOT localized in this language)
- russian: 2% (game NOT localized in this language)
- spanish: 1% (game NOT localized in this language)
- japanese: 1% (game NOT localized in this language)
- schinese: 81%
- brazilian: 0% (game NOT localized in this language)
- german: 0% (game NOT localized in this language)

## Analyst notes (AI-assisted)

A darkly comedic adult visual novel set in a dysfunctional hospital, blending psychological discomfort with character-driven storytelling and explicit content.

Nope Nope Nurses has accumulated $99k lifetime revenue across ~20k units with 77% positive sentiment and steady monthly residual income ($1.1k/mo mid-case). The game carries niche appeal, modest review velocity (9/mo), and a fading studio behind it, making it a quiet catalog acquisition candidate for publishers already managing adult visual novel portfolios or exploring dormant IP revival through localization and platform expansion. The 6% Russian localization gap and strong Asian market presence (428 Chinese reviews) suggest untapped regional revenue.

- Most realistic play: acquisition
- Risk (market): Adult visual novel market is narrow and seasonal; Shiravune's publishing capacity and Dark One!'s fading studio status raise questions about post-acquisition support or sequel likelihood.
- Risk (other): Title carries explicit sexual content and psychological themes; platform storefronts and payment processors have varying tolerance, limiting distribution channels and marketing venues.
- Risk (tech): Built 55+ months ago on unknown engine; localization gaps and language support (3 languages vs. 11+ review languages) suggest porting or expansion would require fresh development investment.

What players are asking for:
- Sequel or continuation with deeper character arcs (especially Tachibana and Kurokawa psychology)
- Console/mobile ports or platform expansion
- Russian and broader CJK localization completion
- Integration with anime franchise IP if available

Suggested first moves:
1. Audit Dark One! and Shiravune IP ownership and publishing rights; confirm full acquisition vs. licensing feasibility and any anime/manga tie-in obligations.
2. Map untapped regional revenue by completing Russian, Korean, and Simplified Chinese localization and testing regional platform launches (Epic, GOG, regional storefronts).
3. Survey the 428 Chinese reviewers and 10+ Korean reviewers on pricing, DLC appetite, and platform preference to prioritize low-risk expansion paths before committing sequel investment.

Generated 2026-08-20 from public signals and player reviews. Directional, not diligence.

## Methodology

Units are estimated from Steam-purchase reviews times a release-cohort multiplier (Boxleiter method, 20-75x by year). Revenue uses an effective price (lifetime discounts and regional pricing) and nets out VAT (~13%), refunds (~9.5%) and Steam's 30% cut: roughly 55% of gross reaches the developer.

Source: https://residualplay.com/game/1846330
Citation: please cite ResidualPlay (https://residualplay.com) when using these estimates.